Heidi Ackerly Wallweber

2.0k total citations · 1 hit paper
6 papers, 1.3k citations indexed

About

Heidi Ackerly Wallweber is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Heidi Ackerly Wallweber has authored 6 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Cell Biology and 2 papers in Immunology. Recurrent topics in Heidi Ackerly Wallweber's work include Endoplasmic Reticulum Stress and Disease (2 papers), vaccines and immunoinformatics approaches (1 paper) and Advanced Biosensing Techniques and Applications (1 paper). Heidi Ackerly Wallweber is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (2 papers), vaccines and immunoinformatics approaches (1 paper) and Advanced Biosensing Techniques and Applications (1 paper). Heidi Ackerly Wallweber collaborates with scholars based in Switzerland, United States and France. Heidi Ackerly Wallweber's co-authors include Jing Zhu, Marcus J. Taylor, Jun Huang, Dibyendu K. Sasmal, Jeanne Cheung, Jeong Kim, Ira Mellman, Enfu Hui, Xiaolei Su and Ronald D. Vale and has published in prestigious journals such as Science, Nature Communications and ACS Medicinal Chemistry Letters.

In The Last Decade

Heidi Ackerly Wallweber

6 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition

2017 1.2k citations Enfu Hui, Jeanne Cheung et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heidi Ackerly Wallweber Switzerland	5	868	840	337	94	78	6	1.3k
Lukas Baitsch Switzerland	13	1.0k 1.2×	935 1.1×	385 1.1×	68 0.7×	108 1.4×	13	1.5k
Chunyan Gu‐Trantien Belgium	16	722 0.8×	742 0.9×	234 0.7×	136 1.4×	113 1.4×	29	1.2k
Nana-Ama A.S. Anang United States	4	762 0.9×	973 1.2×	223 0.7×	162 1.7×	76 1.0×	6	1.2k
Katalin Gilde Hungary	16	638 0.7×	921 1.1×	495 1.5×	113 1.2×	70 0.9×	30	1.3k
Lisa Cucolo United States	3	585 0.7×	668 0.8×	345 1.0×	114 1.2×	104 1.3×	4	1.0k
Inge Verbrugge Netherlands	17	443 0.5×	621 0.7×	555 1.6×	113 1.2×	122 1.6×	23	1.1k
Peter A. Prieto United States	13	659 0.8×	828 1.0×	233 0.7×	82 0.9×	51 0.7×	43	1.1k
Marta Nyakas Norway	21	738 0.9×	1.1k 1.3×	670 2.0×	157 1.7×	99 1.3×	49	1.6k
Dris El Atmioui Netherlands	10	970 1.1×	1.1k 1.3×	661 2.0×	72 0.8×	124 1.6×	14	1.5k
Earl Avramis United States	12	457 0.5×	711 0.8×	347 1.0×	100 1.1×	62 0.8×	15	986

Countries citing papers authored by Heidi Ackerly Wallweber

Since Specialization

Citations

This map shows the geographic impact of Heidi Ackerly Wallweber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Ackerly Wallweber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Ackerly Wallweber more than expected).

Fields of papers citing papers by Heidi Ackerly Wallweber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Ackerly Wallweber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Ackerly Wallweber. The network helps show where Heidi Ackerly Wallweber may publish in the future.

Co-authorship network of co-authors of Heidi Ackerly Wallweber

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Ackerly Wallweber. A scholar is included among the top collaborators of Heidi Ackerly Wallweber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Ackerly Wallweber. Heidi Ackerly Wallweber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Wallweber, Heidi Ackerly, Robert G. Alberstein, Zhonghua Lin, et al.. (2024). Rapid affinity optimization of an anti-TREM2 clinical lead antibody by cross-lineage immune repertoire mining. Nature Communications. 15(1). 8382–8382. 2 indexed citations

2.

Ferri, Elena, Adrien Le Thomas, Heidi Ackerly Wallweber, et al.. (2020). Activation of the IRE1 RNase through remodeling of the kinase front pocket by ATP-competitive ligands. Nature Communications. 11(1). 6387–6387. 30 indexed citations

3.

Beveridge, Ramsay E., Heidi Ackerly Wallweber, Avi Ashkenazi, et al.. (2020). Identification of BRaf-Sparing Amino-Thienopyrimidines with Potent IRE1α Inhibitory Activity. ACS Medicinal Chemistry Letters. 11(12). 2389–2396. 6 indexed citations

4.

Hui, Enfu, Jeanne Cheung, Jing Zhu, et al.. (2017). T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition. Science. 355(6332). 1428–1433. 1180 indexed citations breakdown →

5.

René, Olivier, Benjamin P. Fauber, Gladys de Leon Boenig, et al.. (2014). Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of Action. ACS Medicinal Chemistry Letters. 6(3). 276–281. 63 indexed citations

6.

Kadkhodayan, Saloumeh, Linda O. Elliott, Heidi Ackerly Wallweber, et al.. (2007). Evaluation of Assay Technologies for the Identification of Protein–Peptide Interaction Antagonists. Assay and Drug Development Technologies. 5(4). 501–514. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact